| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
Related Subjects: | Leukaemias in General | Acute Promyelocytic Leukaemia | Acute Myeloblastic Leukaemia (AML) | Acute Lymphoblastic Leukaemia (ALL) | Chronic Lymphocytic Leukaemia (CLL) | Chronic Myeloid Leukaemia (CML) | Hairy Cell Leukaemia | Differentiation Syndrome | Tretinoin (ATRA) | Haemolytic Anaemia | Immune Thrombocytopenic Purpura (ITP)
🧬 Leukaemia is a malignant disorder of the blood and bone marrow characterised by uncontrolled proliferation of abnormal white blood cells. This disrupts normal haematopoiesis → causing anaemia, bleeding, and infection. Different types of leukaemia vary in onset, severity, and prognosis, but all require timely recognition and treatment.
| Type | Incidence | Notes |
|---|---|---|
| ALL 👶 | ~9% | Most common childhood leukaemia; rapid progression if untreated. |
| CML 📉 | ~10% | Adults; linked to Philadelphia chromosome; average age ~64 yrs. |
| CLL 👴 | ~23% | Slow buildup of abnormal B cells; commonest leukaemia in elderly. |
| AML 🧓 | ~27% | Bone marrow packed with myeloid blasts; most cases >50 yrs. |
| Myeloproliferative Disorders 🔄 | ~31% | Include polycythaemia vera, myelofibrosis, essential thrombocythaemia. |
| Category | Key Facts |
|---|---|
| 🔬 Definition | Malignant proliferation of abnormal WBCs in bone marrow → disrupts normal haematopoiesis (anaemia, infection, bleeding). |
| 📖 Classification |
|
| 🧾 Common Types |
|
| ⚠️ Symptoms |
|
| 🧪 Key Investigations |
|
| 💊 Management |
|
| 📈 Prognosis |
|
💡 Exam Tip: Think “Anaemia, Infection, Bleeding” as the classic triad of leukaemia presentation. Always mention bone marrow biopsy for diagnosis and TKIs for CML in finals!
Prognosis depends on type, age, and cytogenetics. ✅ Childhood ALL – cure rates >80%. ✅ CML – near-normal life expectancy with tyrosine kinase inhibitors. ⚠️ AML in elderly – poorer prognosis, but improving with novel therapies. Overall, advances in precision medicine and stem cell transplantation continue to improve survival outcomes.